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Abstract The bifunctional protein PCD/DCoH is both an 
enzyme involved in the phenylalanine hydroxylation system and a 
transcription coactivator forming a 2:2 heterotetrameric com- 
plex with the nuclear transcription factor HNF1. The discovery 
of a bacterial homologue and the expression pattern during 
Xenopus embryogenesis suggest a regulatory function not only 
restricted to HNF1. The crystal structures of the tetrameric rat 
and the dimeric bacterial PCD/DCoH have led to the proposal of 
substrate and HNF1 binding sites. The saddle-shaped ~sheet 
surfaces of the DCoH dimers likely represent binding sites for as 
yet unknown macromolecular interaction partners. Possible 
mechanisms for DCoH-induced transcriptional regulation are 
discussed in the light of the three-dimensional structures. 
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1. Introduction 
Bifunctional proteins with combined catalytic and regula- 
tory properties are rare [1], but there are well established 
cases, e.g. the BirA protein of the E. coli biotin operon which 
acts as a repressor and synthesizes its own co-repressor [2,3]. 
In contrast o the biotin repressor/synthase case, however, the 
connection between the enzymatic activity of pterin-4a-carbi- 
nolamine dehydratase (PCD) and its regulatory function as 
dimerisation cofactor of HNF1 (DCoH) is not well under- 
stood. PCD is involved in the regeneration of tetrahydrobiop- 
terin (BH4), an essential cofactor of phenylalanine hydroxy- 
lase (PAH) and other mono-oxygenases, and catalyses the 
conversion of 4a-hydroxytetrahydrobiopterin to quinoid-dihy- 
drobiopterin [4-8]. Certain human diseases like a mild form of 
hyperphenylalaninemia [9] and the depigmentation disorder 
vitiligo [10] are linked to a lack or deficiency of PCD activity. 
This leads to an accumulation of 7-substituted pterins, which 
act as inhibitors of PAH [11] and thereby interfere with the 
phenylalanine catabolism and the biosynthesis of melanin pig- 
ments. 
The bifunctional character of PCD became obvious when 
its protein sequence was shown to be identical with that of 
DCoH, a protein which had previously been found to stabilize 
the dimeric homeodomain transcription factor HNF1 and to 
enhance its transcriptional ctivity [12-14]. The discovery of a 
bacterial homologue of PCD/DCoH [15] and the temporal 
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and spatial expression pattern of DCoH in Xenopus [16] sug- 
gest that DCoH also functions as a transcriptional regulator 
in an environment free of HNF1. 
2. Three-dimensional structure of PCD/DCoH 
The crystal structure of recombinant PCD/DCoH from rat 
liver was determined independently by us and Alber's group 
at 2.7 and 3.0 ,& resolution, respectively [17,18]. The 103-res- 
idue protein folds into a compact, single domain consisting of 
three a-helices packed from one side against a four-stranded 
antiparallel ~-sheet (Fig. 1A). In this open-faced c~/~ sandwich 
structure the helices run almost parallel to the [3-strands, giv- 
ing rise to a hydrophobic ore formed by helices 2 and 3 and 
[3-strands 24 .  Consistent with its tetrameric oligomerization 
state in solution [19,20] PCD/DCoH forms tetramers with 222 
symmetry in the crystals (Fig. 1B). Each monomer contributes 
one helix (c~-2) to a central, antiparallel 4-helix bundle repre- 
senting the major oligomerization interface. An additional 
interface between monomers A/B and C/D involving the [~- 
strands leads to the formation of 8-stranded intersubunit [3- 
sheets in the A/B and C/D dimers. Thus, the tetramer is prop- 
erly described as a dimer of dimers. The A/B (C/D) dimers are 
further stabilized by intensive hydrophobic contacts of the ct-2 
helices mediated through the stacking of Phe residues and the 
surface buried upon association is about one third larger than 
for the alternative A/C (B/D) dimers. Hence by several criteria 
the A/B dimers are more stable and are likely to be the inter- 
action partners for HNF1 (see below). 
The concave surface of the eight-stranded [3-sheet with ex- 
posed hydrophobic residues flanked by two protruding loops 
on either side is reminiscent of the saddle-shaped TATA-bind- 
ing protein [21-24] (Fig. 2A) and has initiated speculations 
about nucleic acid binding to DCoH. The topology and the 
surface properties of the two proteins are, however, clearly 
different and do not reveal closer similarity to either TBP or 
the RNP RNA-binding motif. Nevertheless, the shape and 
surface properties of the molecular saddle make it a likely 
interaction surface for a macromolecule. 
Recently, we have solved the high-resolution X-ray struc- 
ture of the Pseudomonas aeruginosa PCD/DCoH homologue 
(Ficner et al., unpublished). Interestingly, the P. aeruginosa 
protein crystallizes as a dimer and also exists as a dimer in 
solution (Sauer et al., unpublished results). Compared to the 
rat PCD/DCoH it has a 11-residue N-terminal and 3-residue 
C-terminal extension and displays a 33% sequence identity. 
On the monomer level the two structures uperimpose with 
a root mean square deviation of 2.2 A for 100 common Ca- 
atoms, excluding the N-terminal residues. A close superposi- 
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A quence changes, including N43K, T50N, R51A and K58A, 
are probably also responsible for the failure to detect 
HNF1-DCoH complex formation, when the two proteins 
are coexpressed in E. coli (see below). The N-terminal exten- 
sion of the bacterial protein, which is located next to helix a- 
2, is partially disordered. 
3. Active site of PCD/DCoH 
There is as yet no direct crystallographic confirmation for 
the location of the active site in PCD/DCoH, e.g. in the form 
of an enzyme-inhibitor complex. However, strong support for 
the site proposed independently b two groups based on the 
structure of rat PCD [17,18] has been provided by the X-ray 
structure determination f the P. aeruginosa protein (Ficner et 
al., unpublished) and structure-based site-directed mutagen- 
esis experiments (K6ster et al., unpublished). The proposed 
pterin-binding site is located close to the dimer interface in 
a cleft between loops connecting helix c~-2 with ~-strand 3 and 
strand 4 with helix ct-3 (Fig. 2A). It is lined by a number of 
conserved residues including H61, H62, P63, H79 (the num- 
bering scheme refers to the rat protein [14]), some acidic re- 
sidues and and a tyrosine (tryptophan i  P. aeruginosa) con- 
tributed from the neighbouring subunit (Fig. 3). H61 and H62 
have been shown to be critical for enzymatic activity and are 
apparently activated by ion-pair formation with carboxylates 
a (E57, D88). The aromatic residue contributed from the neigh- 
bouring subunit also appears to be important for activity and 
is presumably involved in subtrate binding (K6ster et al., 
A B 
C D 
Fig. 1. Ribbon presentation of the rat PCD/DCoH monomer (A) 
and tetramer (B) structures. The sequential fold of the monomer is 
ct-[3-13-ct-~-[3-ct. In the tetramer each monomer contributes its c~-2 
helix to the common four-helix bundle. 
tion is found in the putative active site region. However, the 
relative orientation of the monomers in the dimer, which cor- 
responds to the A/B dimer in the rat protein, has changed 
significantly resulting in a 10 A change of the distance be- 
tween the two stirrups of the molecular saddle (Fig. 2B). 
The absence of tetramers can be rationalized by sequence 
changes of residues located on the ~-2 helices, which are crit- 
ical for tetramer stabilization i  the rat structure. These se- 
Fig. 2. (A) Ribbon presentation f the PCD/DCoH dimer. The side 
chains of the active site residues His-61, His-62, His-79 and Tyr-69 
are shown. (B) Superposition of the Ca backbone of the PCD di- 
mers from rat (red) and P.aeruginosa (blue). 
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Fig. 3. Alignment of the amino acid sequences of PCD/DCoH from rat/human liver, Xenopus, yeast and P. aeruginosa. The yeast protein has 
not yet been functionally charaterized. Conserved residues involved in the enzymatic function of PCD/DCoH are highlighted. 
unpublished). The observed quenching of tryptophan fluores- 
cence on pterin-binding to rat PCD [5] can be explained by an 
energy transfer process involving Trp-65. The active site of 
PCD/DCoH is located at the edge of the saddle-shaped sur- 
face of the dimer and one cannot rule out that pterin binding 
affects the association of a macromolecule to this surface. In 
this context, it is interesting to note that complex formation 
with HNF1 has no effect on the dehydratase activity of PCD/ 
DCoH (Rhee et al., unpublished). 
4. Interaction with HNF1 
HNF1 (hepatocyte nuclear factor 1, also called HNF- I~ or 
LFB1) and v-HNFl(also known as HNF-113 or LFB3) are 
members of a family of transcription factors which bind to 
DNA as homo- or heterodimers and regulate the transcrip- 
tion of many genes preferentially expressed in liver (for a re- 
view see [25 27]). Recently, HNF1 was shown to be required 
for the expression of phenylalanine hydroxylase in mice [28]. 
DNA-binding by HNF1 is mediated by the N-terminal 281 
residues which are sequentially organized in three distinct do- 
mains: A short, 32-residue dimerization domain, a region dis- 
tantly related to the POU A-box and an atypical homeodo- 
main, whose structure is known [29]. The latter two domains 
are both necessary and sufficient for specific DNA-recogni- 
tion, while the dimerization domain increases the DNA-bind- 
ing affinity [30]. 
PCD/DCoH copurifies with HNF1 isolated from rat liver 
nuclei and, given the known dimeric nature of HNF1, Mendel 
et al. could show by co-immunoprecipitation experiments hat 
the HNFI /DCoH complex formed by in vitro coexpression is 
a 2:2 heterotetramer [12]. This was later confirmed by gel- 
filtration experiments with complexes obtained by co-expres- 
sion of the proteins in E. coli (Ficner et al., unpublished). 
Using various truncated versions of HNF1 it was demon- 
strated that the N-terminal dimerization domain is necessary 
for complex formation [12]. 
As discussed above the DCoH dimer present in the 2:2 
heterotetrameric complex is most likely the saddle-shaped di- 
mer shown in Fig. 2. The mammalian PCD/DCoH, on the 
other hand, exists as a very stable homotetramer in solution 
and thus dissociation i to dimers is required for complex for- 
mation. How then does DCoH interact with HNF1 and how 
is the complex formed? 
The X-ray structures uggest wo potential interaction sites 
for HNF I :  The antiparallel c~-2 helices on one side, and the 
concave l-sheet surface on the opposite side of the saddle- 
shaped DCoH dimer. The interaction with the [3-sheet appears 
less likely, since mixing of the proteins does not yield any 
complex despite the fact that the [~-sheet surfaces are solvent 
exposed and freely accessible in the DCoH tetramer [17]. In- 
teraction of the dimerization domain with the a-2 helices, on 
the other hand, could lead to the formation of an energetically 
favourable mixed 4-helix bundle. This notion is supported by 
NMR data showing that the dimerization domain of HNF 1 
folds into two helical segments and possibly forms a 4-helix 
bundle [31]. With respect to the formation of the HNF1/ 
DCoH complex in vivo one can only speculate. As mentioned 
above, simple mixing of the proteins does not lead to complex 
formation and preliminary results do not support he possibi- 
lity of a destabilization f the DCoH tetramer by a substrate- 
induced conformational change. There could be other, as yet 
unknown factors affecting the dimer-tetramer quilibrium of 
DCoH or, alternatively, one could conceive of a co-transla- 
tional or folding-dependent event. 
5. Effects of DCoH on nucleic acid binding by HNF1 
As the name indicates, binding of DCoH stabilizes HNF1 
dimers. The evidence for this comes from in vitro experiments 
showing that the exchange of HNF1 subunits is blocked in 
HNFI /DCoH complexes, while HNF1 homo- or heterodi- 
mers can easily exchange subunits [12]. Consistent with a sta- 
bilizing effect of DCoH is the significantly increased enatura- 
tion temperature of the DCoH/HNF1 complex compared to 
HNF1 alone (Rhee et al., unpublished). The stabilization of 
the HNF1 dimer does not seem to affect the DNA-binding 
affinity, but recent experiments using solid-phase DNase I 
footprinting suggest that DCoH enhances the stability of 
HNF I /DNA complexes (Rhee et al., unpublished). The ob- 
served increased resistance against salt-induced issociation 
and significantly longer dissociation off-rates, however, do 
not appear to be the result of direct DCoH-DNA contacts 
as judged by the failure to detect any UV crosslinks. The 
38 D. Suck, P~ Ficner/FEBS Letters 389 (1996) 35-39 
DNase I-footprinting technique also suggests that DCoH ap- 
parently promotes interactions of HNF1 with weak, variant 
target sites. A very surprising result was the detection of 
RNA-binding by HNF1, which is apparently suppressed by 
DCoH (Rhee et al., unpublished). 
6. Other interaction partners of DCoH 
As outlined above, structural and biochemical evidence ar- 
gues against binding of HNF1 in the molecular saddle surface 
of the DCoH dimer. On the other hand, its particular shape 
and surface properties trongly suggest hat it represents an 
interaction interface for a macromolecule. A logical conse- 
quence is that there must be other macromolecular interaction 
partners, either proteins or nucleic acids. This view is strongly 
supported by the identification of the bacterial homologue of 
PCD/DCoH in P. aeruginosa s a product of the phhB gene, 
which apparently is required for the expression of phenylala- 
nine hydroxylase gene (phhA) from the same operon [15]. 
While these results suggest a regulatory role for the bacterial 
DCoH, they leave open the question of whether this is 
achieved through direct interaction with the nucleic acid or 
through another protein. Reports of preliminary results sug- 
gesting that mammalian DCoH can restore steady-state levels 
of phhA mRNA in bacterial cells carrying phhB truncation 
mutations, and that PhhB, the bacterial PCD/DCoH, facili- 
tates expression of HNFl-dependent genes in mammalian 
cells, have triggered speculation on an underlying common 
mechanism for regulation [18]. Cross-species complementation 
of transcriptional control proteins is, however, very unusual 
and needs further verification. 
Additonal evidence for other interaction partners of PCD/ 
DCoH comes from a recent analysis of the spatial and tem- 
poral expression pattern of Xenopus DCoh (XDCoH) during 
embryogenesis [16]. XDCoH is as a maternal factor present in 
the egg before HNF1 is expressed and located in the nuclei as 
early as zygotic transcription starts. The tissue distribution of 
XDCoH during embryogenesis and the location in the nuclei 
of cells devoid of HNF1 suggest hat it has a role in differ- 
entiation and acts as a transcriptional regulator in cell types 
not containing HNF1 [16]. 
7. How does DCoH regulate transcription? 
Knowledge of the 3D structure of DCoH has provided im- 
portant insights into substrate binding and the interaction 
with HNF1, but it is clear that further structural and bio- 
chemical data are needed to unravel the mechanism of tran- 
scriptional regulation by DCoH. The unexpected structural 
features of DCoH have, however, initiated new thoughts 
and hypotheses on how this may work. Considering the pre- 
sently available structural and biochemical data several sce- 
narios are possible. The enhancement of HNFl-dependent 
gene expression could be induced by: (1) Modulation of 
HNF1 binding to DNA. The enhanced stability of HNFI/  
DCoH-DNA complexes and the recognition of variant 
HNF1 target sites argue in favour of such a mechanism 
(Rhee et al., unpublished). DCoH may, for example, promote 
cooperative binding to distant, weak HNF1 binding sites by 
mutual contacts in the saddle surfaces of the DNA-bound 
HNFI/DCoH tetramers, as it is seen in the crystal structure 
[17]. (2) Modulation of HNF1-RNA interactions. New experi- 
mental data suggest hat HNF1 binds RNA and that this 
binding is blocked by DCoH (Rhee et al., unpublished). (3) 
Binding of another protein in the saddle of the DCoH/HNF1 
heterotetramer. 
DCoH appears to have a regulatory function not only in 
the context of HNFl-dependent transciption, but also in bac- 
teria and in Xenopus cells not expressing HNF1 [16,17]. Given 
the (remote) structural similarity of DCoH with RNA-binding 
motifs, direct interaction of DCoH with RNA would there- 
fore be an attractive model providing a universal mechanism 
for the regulatory function. So far, however, there is no ex- 
perimental support for such a model, but further investiga- 
tions and a more thorough search for potential binding sites 
are necessary. 
Finally, it should be pointed out that there is still no estab- 
lished link between the enzymatic activity of PCD/DCoH and 
its regulatory function. A plausible link would be the effect on 
the expression of phenylalanine hydroxylase, which is regu- 
lated by PCD/DCoH in procaryotes and by HNF1 in mam- 
mals [15,28]. However, experimental evidence for a pterin-de- 
pendent transcriptional regulation by DCoH is lacking, but it 
would not be surprising if such a coupling does indeed exist. 
8. Conclusions and perspectives 
The crystal structures of mammalian and bacterial PCD/ 
DCoH combined with structure-based site-directed mutagen- 
esis and new biochemical data have shed light on the enzy- 
matic mechanism and the interaction with HNF1. However, 
there are central issues which remain unresolved: How is the 
DCoH/HNF1 heterotetramer fo med in vivo, given the high 
stability of the DCoH tetramer? What is the mechanism of 
stimulation of HNFl-dependent transcription? What are the 
interaction partners of DCoH in cells and organisms not con- 
taining HNFI? Is there a direct interaction of DCoH with 
DNA or RNA? Finally, one would like to know if and how 
the regulatory function of PCD/DCoH is coupled to its enzy- 
matic activity. 
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